Wahid Khan

Dr. Wahid Khan

orcid

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 March 2011 in BMC Immunology
Verified
Journal Article
Open access
PDF file
MKMohd Wajid Ali Khan
Mohd Wajid Ali Khan
KBKamalpreet Banga
Kamalpreet Banga
SMSubhash N Mashal
Subhash N Mashal
WKWahid Khan
Wahid Khan
Autoantibodies against glutamate decarboxylase-65 (GAD65Abs) are thought to be a major immunological tool involved in pathogenic autoimmunity development in various diseases. GAD65Abs are a sensitive and specific marker for type 1 diabetes (T1D). These autoantibodies can also be found in 6-10% of patients classified with type 2 diabetes (T2D), as well as in 1-2% of the healthy population. The latter individuals are at low risk of developing T1D because the prevalence rate of GAD65Abs is only about 0.3%. It has, therefore, been suggested that the antibody binding to GAD65 in these three different GAD65Ab-positive phenotypes differ with respect to epitope specificity. The specificity of reactive oxygen species modified GAD65 (ROS-GAD65) is already well established in the T1D. However, its association in secondary complications of T1D has not yet been ascertained. Hence this study focuses on identification of autoantibodies against ROS-GAD65 (ROS-GAD65Abs) and quantitative assays in T1D associated complications.


14 December 2015 in Current Drug Metabolism
Verified
Journal Article
Closed access
WKWahid Khan
Wahid Khan
MKMohd Wajid Ali Khan
Mohd Wajid Ali Khan
Cytochrome P450 enzymes are responsible for the hydroxylation of various endogenous estrogens of the Phase I metabolic pathway. Cytochrome P450s produce hormonally active estrogen metabolites that are typically reactive and mutagenic. Although these metabolites are known to have important roles in autoimmunity, the underlying mechanism of this remains unknown. Here we report that cytochrome P450-mediated estrogen metabolites produce high ROS concentrations that can result in DNA damage. Such DNA damage can alter its immunogenicity, resulting in the induction and elevation of autoantibody concentrations, thus generating various autoimmune conditions. Here we focus on the mechanisms through which cytochrome P450-catalyzed estrogen metabolites induce immune responses and subsequently produce the autoimmune phenomenon.

3 August 2009 in Rheumatology
Verified
Journal Article
Open access
PDF file
WKWahid Khan
Wahid Khan
MUMoin Uddin
Moin Uddin
MKMohd Wajid Ali Khan
Mohd Wajid Ali Khan
HCHarvinder S. Chabbra
Harvinder S. Chabbra
It is well established that risk of developing SLE is higher among women compared with men but only very little is understood about the underlying mechanisms. Oestrogen and their catechol metabolites seem to play an important role in SLE but the exact patho-aetiology remains elusive. The evidences concerning the possibility of catecholoestrogens (CEs) in the development of SLE are very limited and preliminary. The possible mechanism involves quinone–semiquinone redox cycling of CEs to generate the free radical that can cause DNA damage. This would probably alter its immunogenicity leading to the induction and elevated levels of SLE autoantibodies cross-reacting with native DNA. The data demonstrate the possible role of CE in presenting unique neo-epitopes that might form one of the factors in induction of SLE autoantibodies. However, the role of oestrogen in immune modulation cannot be rule out as a mediator of various immune-related diseases.

4 September 2010 in Journal of Clinical Immunology
Verified
Journal Article
Closed access
PDF file
WKWahid Khan
Wahid Khan
MOMoinuddin
Moinuddin
AAAbdullah S. Assiri
Abdullah S. Assiri

1 December 2006 in Scandinavian Journal of Immunology
Verified
Journal Article
Closed access
PDF file
WKWahid Khan
Wahid Khan